Home

Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Sunesis Initiates Phase 1 Clinical Trial Of SNS-032 In Patients With B-cell Malignancies Wed, 07 Mar 2007 08:00 AM EST ... Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) announced today the dosing of the first patient in a Phase 1 clinical trial of SNS-032 in patients with advanced B-cell malignancies. [click link for full article] ... MedicalNewsToday - [read full story...] Related Topics Clinical Trials Sickle Cell Anemia Pharmacology Stem Cell Research Trastuzumab Psychopharmacology Small Cell Lung Cancer Tarceva Sickle Cell Skin Cancer AIDS-Related Malignancies Renal Cell Cancer Food Recommendations: South Beach Diet - Phase 2 Food Recommendations: South Beach Diet - Phase 1 Clinical Growth Charts Bevacizumab Injection Blood Cells Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Seizures (in about half of patients) Vaccinations For HIV/AIDs Patients

GoldBambooTM Your Integrative Health and Wellness Resource November 22, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.